Pliva

PLIVA is today the largest pharmaceutical company in Croatia and by sales, the largest in Central and Eastern Europe. Since April 1996, PLIVAs shares have been listed on the London Stock Exchange, a first for a Central and Eastern European manufacturing company...PLIVAs best selling product is its patented oral antibiotic, azithromycin, which PLIVA markets in Central and Eastern Europe under the brand name Sumamed. PLIVAs azithromycin has also been licensed to Pfizer, marketed as Zithromax in the United States and elsewhere. PLIVA also produces and markets drugs under license from a number of multinational pharmaceutical companies.
Concentrating more and more on the global pharmaceutical market,we have spun off our cosmetics and agrochemicals production units as stand alone companies. This to allow to focus more on resources of the development of new chemical and biological entities,new generic pharmaceuticals and the further internationalization of PLIVA operations.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- API / chemicals
- Generics
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic targets:

Markets Covered

a. HeadQuarter: Croatia

b. Continent(s) active: Europe , North America

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:
5271000000	2001	HRK

Year founded: 1921